The CyberKnife at LCRP: A Game-Changer in Prostate Cancer Treatment
Revolutionary Treatment in Our Region
The Nancy N. and J.C. Lewis Cancer & Research Pavilion (LCRP) at St. Joseph’s/Candler is proud to be the only cancer center in the region offering the advanced CyberKnife® Robotic Radiosurgery System.
An effective alternative to surgery, CyberKnife® significantly reduces the duration of treatment while maintaining high success rates.
Precision that moves with you
The CyberKnife® System is a revolutionary robot that delivers Stereotactic Body Radiation Therapy (SBRT), also known as radiosurgery. What sets CyberKnife® apart is its ability to continuously track tumor motion and automatically adjust the radiation beam in real time. Unlike traditional systems, it ensures that the radiation is delivered with sub-millimeter accuracy, even as the body moves. This advanced image guidance technology protects surrounding healthy tissues while targeting the prostate with unmatched accuracy. Benefits to CyberKnife® patients include:
Reduced treatment time
Gone are the days of enduring 40 to 45 radiation sessions over several weeks. With CyberKnife®, the entire treatment course is condensed into just five sessions. This means less time away from work, family, and daily life, offering patients a more convenient and less disruptive experience.
Non-invasive and pain-free
For eligible patients, CyberKnife® eliminates the need for surgery. The procedure is completely non-invasive, allowing patients to lie comfortably while the robotic system delivers treatment. The sessions are entirely pain-free, making it an ideal option for those seeking effective care without the risks and recovery time associated with surgery.
Proven effectiveness
When it comes to results, CyberKnife® is exceptional. Clinical studies show that 93 percent of prostate cancer patients treated with CyberKnife® are disease-free five years after treatment. This level of efficacy provides patients with the confidence to choose a treatment that offers both convenience and long-term success.
CyberKnife differentiators
- Motion tracking technology: A gold fiducial marker is placed in the prostate, allowing the CyberKnife® to track the organ’s movements in real time. This ensures the radiation beam remains precisely focused on the target.
- Streamlined treatment plan: Only five sessions are required, compared to weeks of traditional radiation therapy.
- Patient comfort: The non-invasive procedure is performed without surgery or discomfort.
- Community support: By choosing CyberKnife® at LCRP, you can stay close to home while receiving world-class treatment.
- Remarkable accuracy: Sub-millimeter precision protects surrounding healthy tissue, reducing potential side effects.
Transforming lives
CyberKnife® treatment is recommended for patients with low- to intermediate-risk prostate cancer, generally defined as those with a Gleason score of seven or less. If you or a loved one is considering treatment, consult your doctor to determine if CyberKnife® is the right course of action for your diagnosis.
Imagine fighting prostate cancer with a faster, less invasive, and incredibly effective treatment while remaining near the ones you love. We are proud to offer this groundbreaking option to our community, giving patients access to the same world-class technology found at major cancer centers in metropolitan areas.
Take the first step toward healing
The CyberKnife® at LCRP is not just a treatment option—it’s a beacon of hope for prostate cancer patients in our community. If you or a loved one is exploring treatment options, there has never been a better time to consider CyberKnife®. With reduced treatment times, non-invasive procedures, and proven effectiveness it’s a decision you can make with confidence.
Take charge of your prostate cancer treatment. Consult with your doctor or contact the Nancy N. and J.C. Lewis Cancer & Research Pavilion to learn more about CyberKnife® and determine if it’s the right solution for you.